INDP
INDP
NASDAQ · Biotechnology

Indaptus Therapeutics Inc

$1.76
-0.02 (-1.12%)
As of Mar 31, 5:00 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.71M
Net Income
-161,760
Gross Margin
57.9%
Profit Margin
-9.5%
Rev Growth
+0.4%
D/E Ratio
0.26
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 57.9% 57.9% 57.9%
Operating Margin -12.4% -9.8% -11.2%
Profit Margin -9.5% -10.7% -8.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.71M 1.62M 1.61M
Gross Profit 988.1K 940.2K 931.2K
Operating Income -211,528 -159,869 -179,508
Net Income -161,760 -172,924 -142,728
Gross Margin 57.9% 57.9% 57.9%
Operating Margin -12.4% -9.8% -11.2%
Profit Margin -9.5% -10.7% -8.9%
Rev Growth +0.4% +1.6% -5.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 609.3K 545.1K 593.7K
Total Equity 2.31M 2.18M 2.44M
D/E Ratio 0.26 0.25 0.24
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -256,082 -275,942 -257,647
Free Cash Flow -132,527 -99,336 -105,630